Evidence map›Paper›PMID 36031951›Full record

ArticleAmerican journal of transplantation : official journal of the American Society of Transplantation and the American Society of Transplant Surgeons2022

Prognostic implications of and clinical risk factors for acute lung injury and organizing pneumonia after lung transplantation: Data from a multicenter prospective cohort study.

Elizabeth N Pavlisko, Megan L Neely, Heather Kopetskie, David M Hwang, Carol F Farver, W Dean Wallace, Andrea Arrossi, Peter Illei, Michelle L Sever, Jerry Kirchner and 16 more

Open access · bronzeAbstract readMulticenter Study
In one paragraph

Article in American journal of transplantation : official journal of the American Society of Transplantation and the American Society of Transplant Surgeons, 2022. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 10 papers.

0numbers the graph read from it
0cells of the map it votes in
10citing papers in PubMed
3.5field-weighted citation impact, top 7% of its field
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

10 citing papers in PubMed, 18 citations in OpenAlex.

  1. Identical versus compatible blood typing: investigating best practices in lung transplantation.Transplant international : official journal of the European Society for Organ Transplantation · 2026
    Article
  2. Article
  3. Basiliximab induction immunosuppression and lung transplant outcomes: Propensity analysis in a multicenter cohort.The Journal of heart and lung transplantation : the official publication of the International Society for Heart Transplantation · 2025
    Article
  4. Identification and validation of a threshold for early posttransplant bronchoalveolar fluid hyaluronan that distinguishes lung recipients at risk for chronic lung allograft dysfunction.The Journal of heart and lung transplantation : the official publication of the International Society for Heart Transplantation · 2025
    Article
  5. Diagnostic alignment to optimize inter-rater reliability among lung transplant pathologists.The Journal of heart and lung transplantation : the official publication of the International Society for Heart Transplantation · 2025
    Article
  6. Article
  7. Organizing pneumonia is associated with molecular allograft injury and the development of antibody-mediated rejection.The Journal of heart and lung transplantation : the official publication of the International Society for Heart Transplantation · 2024
    Article
  8. Article
  9. Early posttransplant reductions in club cell secretory protein associate with future risk for chronic allograft dysfunction in lung recipients: results from a multicenter study.The Journal of heart and lung transplantation : the official publication of the International Society for Heart Transplantation · 2023
    Article
  10. Article
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

26 authors at 9 institutions in 2 countries.

Elizabeth N PavliskoDepartment of Pathology, Duke University Medical Center, Durham, North Carolina, USA.ORCID 0000-0001-9598-3369
Megan L NeelyDuke Clinical Research Institute, Duke University Medical Center, Durham, North Carolina, USA.
Heather KopetskieRho, Durham, North Carolina, USA.
David M HwangSunnybrook Health Sciences Centre, Toronto, Ontario, Canada.
Carol F FarverCleveland Clinic, Cleveland, Ohio, USA.
W Dean WallaceUniversity of Southern California, Los Angeles, California, USA.
Andrea ArrossiCleveland Clinic, Cleveland, Ohio, USA.
Peter IlleiJohns Hopkins University, Baltimore, Maryland, USA.
Michelle L SeverRho, Durham, North Carolina, USA.
Jerry KirchnerDuke Clinical Research Institute, Duke University Medical Center, Durham, North Carolina, USA.
Courtney W FrankelDivision of Pulmonary Allergy and Critical Care Medicine, Department of Medicine, Duke University Medical Center, Durham, North Carolina, USA.
Laurie D SnyderDuke Clinical Research Institute, Duke University Medical Center, Durham, North Carolina, USA.ORCID 0000-0002-5962-2184
Tereza MartinuUniversity Health Network, University of Toronto, Toronto, Ontario, Canada.
Michael Y ShinoUniversity of California Los Angeles, Los Angeles, California, USA.ORCID 0000-0001-9261-1404
Lorenzo ZaffiriDivision of Pulmonary Allergy and Critical Care Medicine, Department of Medicine, Duke University Medical Center, Durham, North Carolina, USA.ORCID 0000-0002-8369-4145
Nikki WilliamsNational Institute of Allergy and Infectious Diseases, Rockville, Maryland, USA.
Mark A RobienNational Institute of Allergy and Infectious Diseases, Rockville, Maryland, USA.
Lianne G SingerUniversity Health Network, University of Toronto, Toronto, Ontario, Canada.ORCID 0000-0002-2693-8676
Marie BudevCleveland Clinic, Cleveland, Ohio, USA.
Wayne TsuangCleveland Clinic, Cleveland, Ohio, USA.ORCID 0000-0001-7375-3845
Pali D ShahJohns Hopkins University, Baltimore, Maryland, USA.
John M ReynoldsDivision of Pulmonary Allergy and Critical Care Medicine, Department of Medicine, Duke University Medical Center, Durham, North Carolina, USA.
S Sam WeigtUniversity of California Los Angeles, Los Angeles, California, USA.
John A BelperioUniversity of California Los Angeles, Los Angeles, California, USA.
Scott M PalmerDuke Clinical Research Institute, Duke University Medical Center, Durham, North Carolina, USA.ORCID 0000-0002-1370-3771
Jamie L ToddDuke Clinical Research Institute, Duke University Medical Center, Durham, North Carolina, USA.ORCID 0000-0003-4247-3693
Clinical Research Institute · USCleveland Clinic · USDuke Medical Center · USUniversity of California, Los Angeles · USJohns Hopkins University · USNational Institute of Allergy and Infectious Diseases · USUniversity Health Network · CASunnybrook Health Science Centre · CAUniversity of Southern California · US

Funding

Transplantation GroupUM2AI117870 · NIAID · RHO FEDERAL SYSTEMS DIVISION, INC. · PI DAVID, GLORIA · 2015 to 2023
$208.1M
The Lung Transplant Clinical Trials Network (LT-CTN)U01AI113315 · NIAID · DUKE UNIVERSITY · PI PALMER, SCOTT M · 2014 to 2018
$12.9M
Non-invasive surveillance of the lung allograft post transplantationK23HL138256 · NHLBI · UNIVERSITY OF CALIFORNIA LOS ANGELES · PI SHINO, YUSAKU MICHAEL · 2017 to 2021
$902k
NHLBI NIH HHS K23 HL138256NIAID NIH HHS U01 AI113315NIAID NIH HHS UM2 AI117870NIH HHS UM2AI117870
6 · The paper itself

Abstract

We determined prognostic implications of acute lung injury (ALI) and organizing pneumonia (OP), including timing relative to transplantation, in a multicenter lung recipient cohort. We sought to understand clinical risks that contribute to development of ALI/OP. We analyzed prospective, histologic diagnoses of ALI and OP in 4786 lung biopsies from 803 adult lung recipients. Univariable Cox regression was used to evaluate the impact of early (≤90 days) or late (>90 days) posttransplant ALI or OP on risk for chronic lung allograft dysfunction (CLAD) or death/retransplantation. These analyses demonstrated late ALI/OP conferred a two- to threefold increase in the hazards of CLAD or death/retransplantation; there was no association between early ALI/OP and these outcomes. To determine risk factors for late ALI/OP, we used univariable Cox models considering donor/recipient characteristics and posttransplant events as candidate risks. Grade 3 primary graft dysfunction, higher degree of donor/recipient human leukocyte antigen mismatch, bacterial or viral respiratory infection, and an early ALI/OP event were significantly associated with increased late ALI/OP risk. These data from a contemporary, multicenter cohort underscore the prognostic implications of ALI/OP on lung recipient outcomes, clarify the importance of the timing of these events, and identify clinical risks to target for ALI/OP prevention.

Indexed as

Acute Lung InjuryLung TransplantationPneumoniaAdultCohort StudiesHumansLungPrognosisProspective StudiesRetrospective StudiesRisk Factorsacute lung injurylung transplantationorganizing pneumonia

Identifiers

PMID36031951
PMCPMC9925227
OpenAlexW4293511992

What OpenQuestion holds

Textmetadata
LicenceTDM
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.